Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/67843
標題: Immunogenicity of envelope GP5 protein displayed on baculovirus and protective efficacy against virulent porcine reproductive and respiratory syndrome virus challenge in piglets
作者: Wang, Z.S.
Xu, X.G.
Liu, H.J.
Li, Z.C.
Ding, L.
Yu, G.S.
Xu, D.
Tong, D.W.
關鍵字: Baculovirus surface display;porcine reproductive and respiratory;syndrome virus (PRRSV);GP5 protein;immunogenicity;protective efficacy;recombinant pseudorabies virus;immune-responses;expressing gp5;mammalian-cells;prrsv;gene;influenza;fusion;vector;mice
Project: African Journal of Microbiology Research
期刊/報告no:: African Journal of Microbiology Research, Volume 5, Issue 18, Page(s) 2682-2691.
摘要: 
In the present study, one recombinant baculovirus BacSC-GP5, expressing His6-tagged GP5 with the transmembrane domain (TM) and cytoplasmic domain (CTD) derived from baculovirus envelope protein gp64, was constructed and its immunogenicity and protective efficiency was evaluated in piglets. The results obtained show that, His6-tagged recombinant GP5 was expressed and anchored on the plasma membrane of Sf-9 cells, as revealed by Western blot and confocal microscopy. Immunogold electron microscopy demonstrated that, the GP5 glycoprotein was displayed successfully on the viral surface. Piglets immunized with BacSC-GP5 induced successfully GP5-specific enzyme-linked immunosorbent assay (ELISA) antibody, neutralizing antibody and lymphocyte proliferation response at 6 weeks after primary immunization. An in vivo challenge result indicated that piglets immunized with BacSC-GP5 did not show any obvious clinical signs and histological changes, and the quantitative real-time polymerase chain reaction (RT-PCR) also indicated that the porcine reproductive and respiratory syndrome virus (PRRSV) viral load from the serum in BacSC-GP5 group was significantly reduced at 14 and 21 days post-challenge compared to that in the negative control group. These results indicate that baculovirus-mediated gene delivery can be utilized as an alternative strategy to develop a new generation of vaccine against PRRSV infection.
URI: http://hdl.handle.net/11455/67843
ISSN: 1996-0808
Appears in Collections:期刊論文

Show full item record
 

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.